Host: Robert L. Coleman, MD, FACOG, FACS Guest: Susana Campos, MD, MPH Guest: Ana Oaknin, MD, PhD Are you testing for MSI-H/dMMR in your patients with advanced endometrial cancer? Listen in as Drs. Robert Coleman, Susana Campos, and Ana Oaknin br

Host: Robert L. Coleman, MD, FACOG, FACS Guest: Susana Campos, MD, MPH Guest: Domenica Lorusso, MD, PhD The recent addition of immunotherapy to our armamentarium for endometrial and cervical cancer has shifted the treatment landscape. Listen in a

Host: Lee P. Shulman, MD, FACMG, FACOG Guest: James B. Bussel, MD Program Chairman:Roberto Romero, MD, DMedSciChief, Perinatology Research BranchDivision of Maternal-Fetal Medicine and ObstetricsDivision of Intramural ResearchNICHD/NIH/DHHSEditor-i

Host: Lee Shulman MD, FACOG, FACMG Guest: Ayman Al-Hendy, MD GnRH antagonists are revolutionizing the medical management of uterine fibroids. Drs. Al-Hendy and Shulman discuss how medical myomectomy with GnRH antagonists is revolutionizing care by

Host: Yelena Janjigian, MD Guest: Sam Klempner, MD HER2 is an essential biomarker to be assessed in all patients with gastric/GEJ cancer. Its importance is not only related to its role as a therapeutic target for pathway inhibition, but also to its

Host: Marat Fudim, MD, MHS Despite the use of guideline-directed medical therapy (GDMT), many heart failure (HF) patients may experience worsening symptoms and disease progression. There is now an FDA-approved device that works with GDMT and uses the

Host: Lee Shulman MD, FACOG, FACMG Guest: Elizabeth Stewart, MD Fertility preservation is a significant clinical concern for all women of reproductive age diagnosed with endometriosis or uterine fibroids (UF). Drs. Elizabeth Stewart and Lee Shulman

Host: Benjamin Levy, MD Guest: Rebecca Heist, MD, MPH Guest: Peter Bela Illei, MD Antibody-drug conjugates (ADCs) have promising clinical data in the treatment of advanced non-small cell lung cancer. Listen in as Drs. Benjamin Levy, Rebecca Heist

Host: Eric Van Cutsem, MD, PhD Guest: Elizabeth Smyth, MD Guest: Sunnie Kim, MD Recent immunotherapy approvals for gastric, esophageal, and gastroesophageal junction cancers have transformed the treatment landscape. Listen in as Drs. Eric Van Cut

Host: Maria Fleseriu, MD, FACE Guest: Irina Bancos, MD Cushings disease is complex, and individualized approaches require the consideration of many patient factors. You and your patient also need to know what to expect in terms of therapeutic resp